Press "Enter" to skip to content

AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug

Dapagliflozin, an innovative Type 2 diabetes medicine, is AstraZeneca Pharma’s leading diabetes medicine.

Original source: https://health.economictimes.indiatimes.com/news/pharma/astrazeneca-pharma-inks-distribution-pact-with-abbott-for-diabetes-drug/66982577?utm_source=RSS&utm_medium=ETRSS

Also Read:   Dr Reddy’s to use CMO for vaccine